Experts Gather to Focus on Heart in DMD

Physicians and scientists will meet Jan. 21-22, 2011, in Columbus, Ohio, at an MDA-sponsored conference about cardiomyopathy in Duchenne muscular dystrophy

Article Highlights:
  • MDA is sponsoring an international meeting of experts on heart problems in Duchenne muscular dystrophy on Jan. 21-22 at Nationwide Children’s Hospital in Columbus, Ohio.
  • Attendees include physicians connected with the MDA/DMD Clinical Research Network, as well as other experts in pediatric cardiology and neuromuscular disease from the United States, the United Kingdom, France and Germany.
  • Among the topics to be discussed are pathophysiology, imaging, therapeutics, clinical and genetic observations, and ongoing clinical trials.
by Miriam Davidson on January 18, 2011 - 4:06pm

Experts from around the world will gather Jan. 21-22, 2011, at an MDA-sponsored conference about the heart in Duchenne muscular dystrophy (DMD).

With improvements in the care of people with DMD, life expectancy is increasing, and cardiac complications are common. As a result, cardiac care in DMD is more important than ever. The goal of the conference is to identify problems in the diagnosis and management of cardiomyopathy (cardiac muscle disease) in DMD, as well as in the related disease, Becker muscular dystrophy (BMD), and to improve the conduct of clinical trials.

The two-day meeting, to be held at the Research Institute at Nationwide Children’s Hospital in Columbus, Ohio, is expected to bring together approximately 50 physicians, researchers and others working to address cardiac issues in DMD and BMD.

Among the expected attendees are MDA's Executive Vice President — Research & Medical Director Valerie Cwik; directors and staff from the five centers that make up the MDA/DMD Clinical Research Network; and current and former MDA grantees who study cardiomyopathy in DMD/BMD.

Topics to be discussed are pathophysiology, or what causes heart problems in DMD; imaging, or how heart problems in DMD are diagnosed and analyzed; therapeutics, or how heart problems in DMD are treated; genotypic and phenotypic observations, or correlations between genetic and clinical information; and the conduct of clinical trials related to heart problems in DMD.

Your rating: None Average: 5 (1 vote)
MDA cannot respond to questions asked in the comments field. For help with questions, contact your local MDA office or clinic or email publications@mdausa.org. See comment policy